Non-LDL-related dyslipidaemia and coronary risk: a case-control study (Q42965481)

11 November 2017

Non-LDL-related dyslipidaemia and coronary risk: a case-control study (English)

1 reference

11 November 2017

1 reference

Gerd Assmann

1

1 reference

11 November 2017

Paul Cullen

series ordinal

2

1 reference

11 November 2017

Helmut Schulte

series ordinal

3

1 reference

11 November 2017

language of work or name

English

0 references

publication date

19 July 2010

1 reference

Diabetes and Vascular Disease Research

11 November 2017

1 reference

11 November 2017

7

1 reference

11 November 2017

3

1 reference

11 November 2017

204-212

1 reference

Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates.

11 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Standards of medical care in diabetes--2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Triglycerides and the Risk of Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

When can odds ratios mislead?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Lipid-lowering therapy and cholesterol levels following acute myocardial infarction: a German study of 5361 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Lipoproteins and diabetic microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Peroxisome proliferator-activated receptors in inflammation control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164110372640

21 January 2018

Identifiers

DOI

10.1177/1479164110372640

1 reference

11 November 2017

1 reference